Literature DB >> 29359794

Association of EZH2 protein expression by immunohistochemistry in myelodysplasia related neoplasms with mutation status, cytogenetics and clinical outcomes.

Kathy L McGraw1, Johnny Nguyen2, Najla H Al Ali1, Rami S Komrokji1, David Sallman1, Xiaohui Zhang2, Jinming Song2, Eric Padron1, Jeffrey E Lancet1, Lynn C Moscinski2, Alan F List1, Ling Zhang2.   

Abstract

Entities:  

Keywords:  EZH2; immunohistochemistry; mutation; myelodysplastic syndromes; survival

Mesh：

Substances：

Year:  2018        PMID： 29359794     DOI： 10.1111/bjh.15099

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  1 in total

1.  Aberrant Expression of EZH2 in Pediatric Patients with Myelodysplastic Syndrome: A Potential Biomarker of Leukemic Evolution.

Authors:  Teresa de Souza Fernandez; Tatiana Fonseca Alvarenga; Elaiza Almeida Antônio de Kós; Viviane Lamim Lovatel; Rita de Cássia Tavares; Elaine Sobral da Costa; Cecília de Souza Fernandez; Eliana Abdelhay
Journal:  Biomed Res Int       Date:  2019-12-10       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.